{"entities":{"Q40361":{"pageid":30729,"ns":120,"title":"Item:Q40361","lastrevid":128908,"modified":"2026-08-13T06:08:25Z","type":"item","id":"Q40361","labels":{"mul":{"language":"mul","value":"6C44.2"},"pt-br":{"language":"pt-br","value":"Depend\u00eancia de sedativos, hipn\u00f3ticos ou ansiol\u00edticos"},"en":{"language":"en","value":"Sedative, hypnotic or anxiolytic dependence"}},"descriptions":{"pt-br":{"language":"pt-br","value":"Depend\u00eancia de sedativos, hipn\u00f3ticos ou ansiol\u00edticos \u00e9 um transtorno de regula\u00e7\u00e3o do uso de sedativos que surge do uso repetido ou cont\u00ednuo dessas subst\u00e2ncias. O elemento caracter\u00edstico \u00e9 um forte impulso interno para usar sedativos, hipn\u00f3ticos ou ansiol\u00edticos, que \u00e9 manifestado por capacidade prejudicada de controlar o uso, aumento da prioridade dada ao uso em detrimento de outras atividades, e persist\u00eancia do uso apesar de danos ou consequ\u00eancias negativas. Essas experi\u00eancias s\u00e3o frequentemente acompanhadas de uma sensa\u00e7\u00e3o subjetiva de urg\u00eancia ou fissura para usar essas subst\u00e2ncias. Aspectos fisiol\u00f3gicos da depend\u00eancia tamb\u00e9m podem estar presentes, incluindo a toler\u00e2ncia aos efeitos de sedativos, hipn\u00f3ticos ou ansiol\u00edticos, sintomas de abstin\u00eancia ap\u00f3s a cessa\u00e7\u00e3o ou redu\u00e7\u00e3o no uso, ou uso repetido de sedativos ou subst\u00e2ncias farmacologicamente semelhantes para prevenir ou aliviar os sintomas de abstin\u00eancia. As manifesta\u00e7\u00f5es da depend\u00eancia geralmente s\u00e3o evidentes durante um per\u00edodo de pelo menos 12 meses, mas o diagn\u00f3stico pode ser feito se o uso de sedativos for cont\u00ednuo (di\u00e1rio ou quase di\u00e1rio) por pelo menos 3 meses."},"en":{"language":"en","value":"Sedative, hypnotic or anxiolytic dependence is a disorder of regulation of sedative use arising from repeated or continuous use of these substances. The characteristic feature is a strong internal drive to use sedatives, hypnotics, or anxiolytics, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use these substances. Physiological features of dependence may also be present, including tolerance to the effects of sedatives, hypnotics or anxiolytics, withdrawal symptoms following cessation or reduction in use, or repeated use of sedatives or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if sedative use is continuous (daily or almost daily) for at least 3 months."}},"aliases":{},"claims":{"P68":[{"mainsnak":{"snaktype":"value","property":"P68","hash":"0701d2c18951b8b7d325559a44ad999c5f8766c1","datavalue":{"value":"https://id.who.int/icd/entity/1605607466","type":"string"},"datatype":"url"},"type":"statement","id":"Q40361$AD34EF4A-608F-4374-A0F7-DFDC301EE83C","rank":"normal"}],"P67":[{"mainsnak":{"snaktype":"value","property":"P67","hash":"ed0e710e89dfe4278838e5158db6b733607f5c03","datavalue":{"value":"CID11:6C44.2","type":"string"},"datatype":"string"},"type":"statement","id":"Q40361$46158F0E-20DE-4970-9EAF-0B0E4D5804E0","rank":"normal"}],"P70":[{"mainsnak":{"snaktype":"value","property":"P70","hash":"f28e98efd08e7ae5041baeae791c2330208b2395","datavalue":{"value":"dki-india-6C44.2","type":"string"},"datatype":"string"},"type":"statement","id":"Q40361$D768A97E-54A8-4039-8BCB-FA7302A8605A","rank":"normal"}],"P86":[{"mainsnak":{"snaktype":"value","property":"P86","hash":"a96031634b9f5dafddaf781bbba3adea6bb64ef4","datavalue":{"value":"Conclu\u00eddo","type":"string"},"datatype":"string"},"type":"statement","id":"Q40361$FD14770D-274E-4B9F-B012-4A55DF5BED9A","rank":"normal"}],"P78":[{"mainsnak":{"snaktype":"value","property":"P78","hash":"5f9b5be68b7400da549761cf15abfdbc4d1e075b","datavalue":{"value":"https://pauloleads.com.br/cases-publicos/","type":"string"},"datatype":"url"},"type":"statement","id":"Q40361$33576B24-57C0-4A8B-A571-2BEE8AC4D9AF","rank":"normal"}],"P80":[{"mainsnak":{"snaktype":"value","property":"P80","hash":"92b8222fcbb75718504f915073a3f43bd4003d18","datavalue":{"value":{"time":"+2026-08-13T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q40361$6CE05F06-5A1D-435F-86CE-297CCE7D26B4","rank":"normal"}],"P89":[{"mainsnak":{"snaktype":"value","property":"P89","hash":"368499027c81ea0c28bb27041a074a8a5b9be04d","datavalue":{"value":{"entity-type":"item","numeric-id":15961,"id":"Q15961"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q40361$874EA1BB-3097-4625-AD74-A7BF606EC8B5","rank":"normal"}]},"sitelinks":{}}}}